Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionchromatin binding

MTA2 PHC3 NCOA6 TNRC18 PCGF2 TP63 PER1 SMARCC1 MBD6 ARID1A CREBBP EP300

4.74e-067396612GO:0003682
GeneOntologyMolecularFunctionSH3 domain binding

WIPF1 SYNJ1 WASF2 ARHGAP17 SOCS7 SOS1

7.75e-06143666GO:0017124
GeneOntologyMolecularFunctionpeptide lactyltransferase (CoA-dependent) activity

CREBBP EP300

1.08e-052662GO:0120300
GeneOntologyMolecularFunctionhistone H3K27 acetyltransferase activity

CREBBP EP300

1.08e-052662GO:0044017
GeneOntologyMolecularFunctionprotein domain specific binding

NCOA6 WIPF1 SYNJ1 ATXN2 MUC17 TP63 WASF2 ARHGAP17 TRAK2 CREBBP SOCS7 SOS1

2.58e-058756612GO:0019904
GeneOntologyMolecularFunctionhistone H3K18 acetyltransferase activity

CREBBP EP300

3.22e-053662GO:0043993
GeneOntologyMolecularFunctionperoxisome proliferator activated receptor binding

NCOA6 CREBBP EP300

4.40e-0521663GO:0042975
GeneOntologyMolecularFunctiontranscription coactivator activity

MTA2 NCOA6 SMARCC1 TAF6 ARID1A CREBBP EP300

6.26e-05303667GO:0003713
GeneOntologyMolecularFunctiontranscription coregulator activity

MTA2 IRF2BP2 NCOA6 JAZF1 SMARCC1 TAF6 ARID1A CREBBP EP300

9.22e-05562669GO:0003712
GeneOntologyMolecularFunctioncytoskeletal protein binding

GPHN TTBK1 WIPF1 KIF26A MICAL2 WASF2 MAST1 FMN2 TRAK2 MAST2 EP300 MPRIP

2.27e-0410996612GO:0008092
GeneOntologyMolecularFunctionchromatin DNA binding

MTA2 PER1 SMARCC1 CREBBP EP300

2.28e-04167665GO:0031490
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

MTA2 IRF2BP2 NCOA6 RBM33 JAZF1 SMARCC1 ZC3H18 TAF6 ARID1A CREBBP EP300 SOS1

3.72e-0411606612GO:0030674
GeneOntologyMolecularFunctionmolecular adaptor activity

MTA2 GPHN IRF2BP2 NCOA6 RBM33 JAZF1 SMARCC1 ZC3H18 TAF6 ARID1A CREBBP EP300 SOS1

4.27e-0413566613GO:0060090
GeneOntologyMolecularFunctionhistone H3 acetyltransferase activity

CREBBP EP300

1.10e-0315662GO:0010484
GeneOntologyMolecularFunctionprotein serine kinase activity

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

1.26e-03363666GO:0106310
GeneOntologyMolecularFunctionnuclear glucocorticoid receptor binding

NCOA6 EP300

1.97e-0320662GO:0035259
GeneOntologyMolecularFunctionp53 binding

TP63 CREBBP EP300

2.12e-0377663GO:0002039
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

MTA2 NCOA6 TAF6 ARID1A CREBBP EP300

2.53e-03417666GO:0061629
GeneOntologyMolecularFunctionpromoter-specific chromatin binding

PCGF2 TP63 EP300

2.62e-0383663GO:1990841
GeneOntologyMolecularFunctiondamaged DNA binding

TP63 CREBBP EP300

2.72e-0384663GO:0003684
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

MTA2 NCOA6 PER1 TAF6 ARID1A CREBBP EP300

3.03e-03582667GO:0140297
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

3.52e-03446666GO:0004674
GeneOntologyMolecularFunctionnucleosome binding

MTA2 SMARCC1 ARID1A

4.19e-0398663GO:0031491
GeneOntologyBiologicalProcessregulation of T cell differentiation

CD2 SMARCC1 ARID1A IL4R EP300 SOS1 SOS2

7.01e-06226657GO:0045580
GeneOntologyBiologicalProcessregulation of lymphocyte differentiation

CD2 SMARCC1 ARID1A IL4R EP300 SOS1 SOS2

2.02e-05266657GO:0045619
GeneOntologyBiologicalProcessN-terminal peptidyl-lysine acetylation

CREBBP EP300

5.84e-054652GO:0018076
GeneOntologyBiologicalProcessnegative regulation of transcription by RNA polymerase II

MTA2 IRF2BP2 CUX2 PCGF2 AEBP1 TP63 PER1 JAZF1 ARID1A ZBTB42 CREBBP EP300

9.65e-0510536512GO:0000122
GeneOntologyBiologicalProcesshead development

NES NCOA6 TTBK1 ATXN2 KIF26A MAST1 ARID1A CREBBP EP300 SOCS7 SOS1

1.28e-049196511GO:0060322
HumanPhenoPlantar crease between first and second toes

CREBBP EP300

2.71e-052272HP:0008107
HumanPhenoAortic isthmus hypoplasia

CREBBP EP300

2.71e-052272HP:0034227
HumanPhenoHigh axial triradius

CREBBP EP300

2.71e-052272HP:0001042
HumanPhenoKeloids

AEBP1 CREBBP EP300

3.67e-0513273HP:0010562
HumanPhenoLaryngeal cartilage malformation

CREBBP EP300

8.09e-053272HP:0008752
HumanPhenoPhobia

CREBBP EP300

8.09e-053272HP:5200232
HumanPhenoAgoraphobia

CREBBP EP300

8.09e-053272HP:0000756
HumanPhenoHumoral immunodeficiency

CREBBP EP300

8.09e-053272HP:0005363
HumanPhenoProminent nasal septum

CREBBP EP300

8.09e-053272HP:0005322
HumanPhenoRadial deviation of thumb terminal phalanx

CREBBP EP300

8.09e-053272HP:0005895
HumanPhenoShort stepped shuffling gait

SYNJ1 ATXN2 PODXL

8.60e-0517273HP:0007311
HumanPhenoFacial hirsutism

TP63 CREBBP EP300

1.03e-0418273HP:0009937
HumanPhenoTrichiasis

CREBBP EP300

1.61e-044272HP:0001128
HumanPhenoVisceral hemangioma

CREBBP EP300

1.61e-044272HP:0410266
HumanPhenoTalon cusp

CREBBP EP300

1.61e-044272HP:0011087
HumanPhenoWidened distal phalanges

CREBBP EP300

1.61e-044272HP:0006200
HumanPhenoVascular ring

CREBBP EP300

1.61e-044272HP:0010775
HumanPhenoHepatic hemangioma

CREBBP EP300

1.61e-044272HP:0031207
HumanPhenoLocalized hirsutism

TP63 CREBBP EP300

1.66e-0421273HP:0009889
HumanPhenoPanic attack

SYNJ1 PODXL CREBBP EP300

1.78e-0455274HP:0025269
HumanPhenoNon-epileptic seizure

SYNJ1 PODXL CREBBP EP300

1.91e-0456274HP:0033052
HumanPhenoReduced social responsiveness

GPHN CUX2 SYNJ1 PODXL CREBBP EP300

2.09e-04170276HP:0012760
HumanPhenoAbnormality of the scalp hair

PCGF2 AEBP1 TP63 TAF6 ARID1A CREBBP EP300 SOS1 SOS2

2.49e-04433279HP:0100037
HumanPhenoVentral hernia

AEBP1 POGZ

2.68e-045272HP:0002933
HumanPhenoPapillary cystadenoma of the epididymis

CREBBP EP300

2.68e-045272HP:0009715
HumanPhenoSupernumerary cusp

CREBBP EP300

2.68e-045272HP:0033777
HumanPhenoEpididymal neoplasm

CREBBP EP300

2.68e-045272HP:0030421
HumanPhenoLow posterior hairline

AEBP1 CREBBP EP300 SOS1 SOS2

3.16e-04117275HP:0002162
HumanPhenoAbnormality of the posterior hairline

AEBP1 CREBBP EP300 SOS1 SOS2

3.16e-04117275HP:0030141
HumanPhenoAbnormal facial expression

SYNJ1 ATXN2 PODXL TP63 CREBBP EP300

3.31e-04185276HP:0005346
HumanPhenoAbnormal scalp morphology

PCGF2 AEBP1 TP63 TAF6 ARID1A CREBBP EP300 SOS1 SOS2

3.34e-04450279HP:0001965
HumanPhenoUreteral duplication

TP63 POGZ CSPP1 SOS1

3.82e-0467274HP:0000073
HumanPhenoMitral valve prolapse

PCGF2 AEBP1 FMN2 CREBBP EP300

3.99e-04123275HP:0001634
HumanPhenoSlowed slurred speech

SYNJ1 PODXL

4.01e-046272HP:0007164
HumanPhenoLarge foramen magnum

CREBBP EP300

4.01e-046272HP:0002700
HumanPhenoMelanocytic nevus

PCGF2 TP63 SOS1 SOS2

4.04e-0468274HP:0000995
HumanPhenoAbnormal lateral ventricle morphology

KIF26A PTPN23 CSPP1 CREBBP EP300

4.97e-04129275HP:0030047
HumanPhenoWeak voice

SYNJ1 ATXN2 PODXL

5.41e-0431273HP:0001621
HumanPhenoAbsence of stomach bubble on fetal sonography

KIF26A ZBTB42

5.59e-047272HP:0010963
HumanPhenoDeviated nasal septum

CREBBP EP300

5.59e-047272HP:0004411
HumanPhenoFeeding difficulties in infancy

PCGF2 TP63 PTPN23 POGZ ARID1A CSPP1 CREBBP EP300 SOS1 SOS2

5.70e-045942710HP:0008872
HumanPhenoPatent ductus arteriosus

PCGF2 TP63 POGZ ARID1A CREBBP EP300 SOS1 SOS2

5.79e-04382278HP:0001643
HumanPhenoAbnormality of the hairline

AEBP1 TAF6 ARID1A CREBBP EP300 SOS1 SOS2

6.48e-04294277HP:0009553
HumanPhenoAspiration

GPHN CREBBP EP300

7.12e-0434273HP:0002835
HumanPhenoObstructive sleep apnea

PCGF2 POGZ CREBBP EP300

7.17e-0479274HP:0002870
HumanPhenoAbnormal number of permanent teeth

TP63 CREBBP EP300

7.76e-0435273HP:0011044
HumanPhenoAbnormal stomach morphology

GPHN IRF2BP2 PCGF2 SYNJ1 KIF26A PODXL POGZ ZBTB42 CSPP1 CREBBP EP300

8.13e-047422711HP:0002577
HumanPhenoDisturbance of facial expression

TP63 CREBBP EP300

8.44e-0436273HP:0005324
HumanPhenoNasolacrimal duct obstruction

TP63 CREBBP EP300

8.44e-0436273HP:0000579
HumanPhenoAbnormal mitral valve morphology

PCGF2 AEBP1 FMN2 CREBBP EP300

8.76e-04146275HP:0031477
HumanPhenoNasogastric tube feeding in infancy

TP63 CREBBP EP300

9.15e-0437273HP:0011470
HumanPhenoAccessory spleen

CSPP1 CREBBP EP300

9.15e-0437273HP:0001747
HumanPhenoPilomatrixoma

CREBBP EP300

9.52e-049272HP:0030434
HumanPhenoCervical cord compression

CREBBP EP300

9.52e-049272HP:0002341
HumanPhenoAbnormal hair quantity

PCGF2 AEBP1 KIF26A TP63 JAZF1 POGZ TAF6 ARID1A CREBBP EP300 SOS1 SOS2

9.77e-048882712HP:0011362
HumanPhenoDeviation of the hallux

AEBP1 TP63 CREBBP EP300

1.08e-0388274HP:0010051
HumanPhenoThick eyebrow

TP63 TAF6 ARID1A CREBBP EP300

1.11e-03154275HP:0000574
HumanPhenoNarrow mouth

PCGF2 TP63 POGZ TAF6 CREBBP EP300

1.16e-03234276HP:0000160
HumanPhenoAbnormality of mouth size

PCGF2 TP63 POGZ TAF6 ARID1A CREBBP EP300 SOS1

1.18e-03425278HP:0011337
HumanPhenoDental malocclusion

PCGF2 TP63 CREBBP EP300 SOS1

1.18e-03156275HP:0000689
HumanPhenoFrontal hirsutism

CREBBP EP300

1.19e-0310272HP:0011335
HumanPhenoCongenital abnormal hair pattern

AEBP1 TAF6 ARID1A CREBBP EP300 SOS1 SOS2

1.22e-03327277HP:0011361
HumanPhenoShuffling gait

SYNJ1 ATXN2 PODXL

1.33e-0342273HP:0002362
HumanPhenoEnlarged thorax

PCGF2 CSPP1 SOS1 SOS2

1.38e-0394274HP:0100625
HumanPhenoAbnormal subclavian artery morphology

CREBBP EP300

1.44e-0311272HP:0031251
HumanPhenoSandal gap

AEBP1 ARID1A CREBBP EP300

1.49e-0396274HP:0001852
MousePhenoprenatal lethality, incomplete penetrance

MTA2 NES NCOA6 TNRC18 CUX2 AEBP1 ATXN2 AMOT TP63 POGZ CREBBP EP300 SOS1

5.83e-067475613MP:0011101
MousePhenoembryonic lethality, incomplete penetrance

MTA2 NES NCOA6 AMOT TP63 POGZ CREBBP EP300 SOS1

3.28e-05410569MP:0011102
MousePhenoprenatal lethality prior to heart atrial septation, incomplete penetrance

MTA2 NES NCOA6 AMOT TP63 POGZ CREBBP EP300 SOS1

3.28e-05410569MP:0031660
MousePhenopericardial effusion

NCOA6 WASF2 ARID1A EP300 SOS1

7.98e-05111565MP:0005312
MousePhenoembryonic lethality during organogenesis, incomplete penetrance

NES NCOA6 AMOT POGZ CREBBP EP300 SOS1

9.15e-05268567MP:0011108
DomainNuc_rcpt_coact_CREBbp

CREBBP EP300

1.12e-052632IPR014744
DomainHAT_KAT11

CREBBP EP300

1.12e-052632PF08214
DomainKIX

CREBBP EP300

1.12e-052632PS50952
DomainZnF_TAZ

CREBBP EP300

1.12e-052632SM00551
DomainCBP_P300_HAT

CREBBP EP300

1.12e-052632IPR031162
DomainDUF902

CREBBP EP300

1.12e-052632PF06001
Domain-

CREBBP EP300

1.12e-0526321.20.1020.10
DomainRING_CBP-p300

CREBBP EP300

1.12e-052632IPR010303
Domain-

CREBBP EP300

1.12e-0526321.10.1630.10
DomainCreb_binding

CREBBP EP300

1.12e-052632PF09030
Domain-

CREBBP EP300

1.12e-0526321.10.246.20
Domainzf-TAZ

CREBBP EP300

1.12e-052632PF02135
DomainZF_TAZ

CREBBP EP300

1.12e-052632PS50134
DomainHistone_AcTrfase_Rtt109/CBP

CREBBP EP300

1.12e-052632IPR013178
DomainKAT11

CREBBP EP300

1.12e-052632SM01250
DomainZnf_TAZ

CREBBP EP300

1.12e-052632IPR000197
DomainKIX_dom

CREBBP EP300

1.12e-052632IPR003101
DomainKIX

CREBBP EP300

1.12e-052632PF02172
DomainCBP_P300_HAT

CREBBP EP300

1.12e-052632PS51727
DomainDUF1908

MAST1 MAST2

6.69e-054632PF08926
DomainMA_Ser/Thr_Kinase_dom

MAST1 MAST2

6.69e-054632IPR015022
DomainMAST_pre-PK_dom

MAST1 MAST2

6.69e-054632IPR023142
Domain-

MAST1 MAST2

6.69e-0546321.20.1480.20
DomainNuc_rcpt_coact

CREBBP EP300

1.67e-046632IPR009110
DomainGDS_CDC24_CS

DNMBP SOS1 SOS2

3.07e-0439633IPR001331
DomainKinase-like_dom

TTBK1 MAP4K1 SMARCC1 MAST1 MAP3K21 MAST2 WNK4 SOS1

4.55e-04542638IPR011009
DomainBAH

MTA2 TNRC18

6.04e-0411632SM00439
DomainBAH

MTA2 TNRC18

6.04e-0411632PF01426
DomainBAH

MTA2 TNRC18

6.04e-0411632PS51038
DomainBAH_dom

MTA2 TNRC18

6.04e-0411632IPR001025
DomainRas_G-nucl-exch_fac_CS

SOS1 SOS2

9.93e-0414632IPR019804
DomainWH2

WIPF1 WASF2

9.93e-0414632SM00246
DomainBAR

ARHGAP17 DNMBP

1.14e-0315632SM00721
DomainBAR

ARHGAP17 DNMBP

1.14e-0315632PF03114
DomainDH_1

DNMBP SOS1 SOS2

1.26e-0363633PS00741
DomainSer/Thr_kinase_AS

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

1.27e-03357636IPR008271
DomainBAR_dom

ARHGAP17 DNMBP

1.30e-0316632IPR004148
DomainWH2

WIPF1 WASF2

1.30e-0316632PF02205
DomainS_TKc

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

1.31e-03359636SM00220
DomainPROTEIN_KINASE_ST

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

1.36e-03362636PS00108
DomainRhoGEF

DNMBP SOS1 SOS2

1.57e-0368633SM00325
Domain-

TAF6 SOS1 SOS2

1.64e-03696331.10.20.10
DomainZZ

CREBBP EP300

1.65e-0318632PF00569
DomainZF_ZZ_2

CREBBP EP300

1.65e-0318632PS50135
DomainZF_ZZ_1

CREBBP EP300

1.65e-0318632PS01357
DomainRhoGEF

DNMBP SOS1 SOS2

1.70e-0370633PF00621
DomainDH_2

DNMBP SOS1 SOS2

1.70e-0370633PS50010
DomainDH-domain

DNMBP SOS1 SOS2

1.78e-0371633IPR000219
Domain-

DNMBP SOS1 SOS2

1.78e-03716331.20.900.10
DomainZnf_ZZ

CREBBP EP300

1.85e-0319632IPR000433
DomainBAR

ARHGAP17 DNMBP

1.85e-0319632PS51021
DomainZnF_ZZ

CREBBP EP300

1.85e-0319632SM00291
DomainRasGEFN

SOS1 SOS2

2.05e-0320632SM00229
DomainRasGEF_N

SOS1 SOS2

2.26e-0321632PF00618
DomainWH2_dom

WIPF1 WASF2

2.26e-0321632IPR003124
DomainRas-like_Gua-exchang_fac_N

SOS1 SOS2

2.48e-0322632IPR000651
DomainRASGEF_NTER

SOS1 SOS2

2.48e-0322632PS50212
DomainHistone-fold

TAF6 SOS1 SOS2

2.77e-0383633IPR009072
DomainWH2

WIPF1 WASF2

2.95e-0324632PS51082
DomainRASGEF

SOS1 SOS2

3.45e-0326632PS00720
DomainBromodomain_CS

CREBBP EP300

3.45e-0326632IPR018359
DomainSANT_dom

MTA2 SMARCC1

3.45e-0326632IPR017884
DomainSANT

MTA2 SMARCC1

4.00e-0328632PS51293
DomainRASGEF_CAT

SOS1 SOS2

4.29e-0329632PS50009
DomainPROTEIN_KINASE_ATP

TTBK1 MAP4K1 MAST1 MAP3K21 MAST2 WNK4

4.44e-03459636PS00107
Domain-

ARHGAP17 DNMBP

4.58e-03306321.20.1270.60
DomainRasGEF

SOS1 SOS2

4.58e-0330632PF00617
PathwayBIOCARTA_VDR_PATHWAY

SMARCC1 ARID1A CREBBP EP300

9.00e-0722494MM1370
PathwayBIOCARTA_VDR_PATHWAY

SMARCC1 ARID1A CREBBP EP300

1.30e-0624494M13404
PathwaySIG_IL4RECEPTOR_IN_B_LYPHOCYTES

MAP4K1 IL4R SOS1 SOS2

2.13e-0627494M1718
PathwayREACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN

PHC3 SMARCC1 ARID1A EP300

5.53e-0634494MM15531
PathwayREACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN

PHC3 SMARCC1 ARID1A EP300

7.82e-0637494M27797
PathwayKEGG_JAK_STAT_SIGNALING_PATHWAY

CREBBP IL4R EP300 SOCS7 SOS1 SOS2

1.52e-05155496M17411
PathwayREACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS

PHC3 PCGF2 CREBBP EP300

1.58e-0544494M27295
PathwayREACTOME_RORA_ACTIVATES_GENE_EXPRESSION

NCOA6 CREBBP EP300

3.10e-0518493M26942
PathwayKEGG_DORSO_VENTRAL_AXIS_FORMATION

FMN2 SOS1 SOS2

7.59e-0524493M11190
PathwayKEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119

PHC3 PCGF2 MBD6

9.70e-0526493M47923
PathwayKEGG_RENAL_CELL_CARCINOMA

CREBBP EP300 SOS1 SOS2

9.98e-0570494M13266
PathwayREACTOME_CIRCADIAN_CLOCK

NCOA6 PER1 CREBBP EP300

9.98e-0570494M938
PathwayBIOCARTA_PELP1_PATHWAY

CREBBP EP300

1.18e-045492MM1575
PathwayREACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES

CREBBP EP300

1.18e-045492M48020
PathwayREACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES

CREBBP EP300

1.18e-045492M48023
PathwayREACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION

CREBBP EP300

1.18e-045492M27228
PathwayWP_KLEEFSTRA_SYNDROME

NCOA6 SMARCC1 ARID1A

1.35e-0429493M48076
PathwayWP_ESTROGEN_SIGNALING

TAF6 CREBBP EP300 SOS1

1.45e-0477494MM15934
PathwayBIOCARTA_PELP1_PATHWAY

CREBBP EP300

1.76e-046492M22062
PathwayWP_EGFEGFR_SIGNALING

SYNJ1 ATXN2 MAP4K1 SOS1 SOS2

2.39e-04162495M39334
PathwayBIOCARTA_PPARG_PATHWAY

CREBBP EP300

2.46e-047492MM1573
PathwayKEGG_PROSTATE_CANCER

CREBBP EP300 SOS1 SOS2

2.53e-0489494M13191
PathwayBIOCARTA_PPARG_PATHWAY

CREBBP EP300

3.27e-048492M22058
PathwayREACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES

CREBBP EP300

3.27e-048492M48022
PathwayREACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION

CREBBP EP300

3.27e-048492M48024
PathwayREACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES

CREBBP EP300

3.27e-048492M46443
PathwayREACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS

PHC3 PCGF2 EP300

3.56e-0440493MM15000
PathwayKEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY

CREBBP EP300

4.20e-049492M47451
PathwayREACTOME_RAC1_GTPASE_CYCLE

WIPF1 WASF2 ARHGAP17 SOS1 SOS2

4.30e-04184495M41809
PathwayBIOCARTA_HSWI_SNF_PATHWAY

SMARCC1 ARID1A

5.23e-0410492MM1532
PathwayKEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS

SOS1 SOS2

5.23e-0410492M47930
PathwayREACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION

CREBBP EP300

5.23e-0410492M27945
PathwayWP_THERMOGENESIS

SMARCC1 ARID1A SOS1 SOS2

5.29e-04108494M39746
PathwaySIG_BCR_SIGNALING_PATHWAY

MAP4K1 SOS1 SOS2

5.39e-0446493M8626
PathwayWP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER

MAP4K1 SMARCC1 ARID1A SOS1

5.67e-04110494M48043
PathwayREACTOME_ADIPOGENESIS

MTA2 NCOA6 CREBBP EP300

5.67e-04110494M48259
PathwayBIOCARTA_CARM1_PATHWAY

CREBBP EP300

6.38e-0411492MM1521
PathwayREACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES

CREBBP EP300

6.38e-0411492M48021
PathwayREACTOME_INTERLEUKIN_15_SIGNALING

SOS1 SOS2

6.38e-0411492MM15578
PathwayREACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR

CREBBP EP300

6.38e-0411492M26924
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY

SOS1 SOS2

6.38e-0411492M47436
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY

SOS1 SOS2

6.38e-0411492M47432
PathwayREACTOME_HEME_SIGNALING

NCOA6 CREBBP EP300

6.50e-0449493M41832
PathwayBIOCARTA_CARM1_PATHWAY

CREBBP EP300

7.64e-0412492M7968
PathwayREACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS

CREBBP EP300

7.64e-0412492M27765
PathwayBIOCARTA_HSWI_SNF_PATHWAY

SMARCC1 ARID1A

7.64e-0412492M22006
PathwayPID_KIT_PATHWAY

MAP4K1 CREBBP SOS1

7.74e-0452493M231
PathwayPID_AR_TF_PATHWAY

SMARCC1 CREBBP EP300

8.18e-0453493M151
PathwayREACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS

NCOA6 PCGF2 CREBBP EP300

8.37e-04122494M29689
PathwayWP_IL4_SIGNALING

IL4R EP300 SOS1

8.64e-0454493M39720
PathwayREACTOME_RHO_GTPASE_CYCLE

SRRM1 WIPF1 WASF2 ARHGAP17 DNMBP SOS1 SOS2

8.68e-04450497M27078
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY

SOS1 SOS2

9.01e-0413492M47594
PathwayREACTOME_ACTIVATION_OF_RAC1

SOS1 SOS2

9.01e-0413492M6322
PathwayKEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47364
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47365
PathwayKEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47366
PathwayKEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47390
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47378
PathwayREACTOME_RUNX3_REGULATES_NOTCH_SIGNALING

CREBBP EP300

1.05e-0314492M27808
PathwayREACTOME_INTERLEUKIN_15_SIGNALING

SOS1 SOS2

1.05e-0314492M27858
PathwayKEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.05e-0314492M47488
PathwayBIOCARTA_RELA_PATHWAY

CREBBP EP300

1.21e-0315492MM1339
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47367
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47389
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47375
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47380
PathwayKEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47592
PathwayKEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47593
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47640
PathwayBIOCARTA_RELA_PATHWAY

CREBBP EP300

1.21e-0315492M10183
PathwayBIOCARTA_PITX2_PATHWAY

CREBBP EP300

1.21e-0315492MM1439
PathwayKEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47485
PathwayKEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47473
PathwayKEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47474
PathwayKEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47475
PathwayKEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47480
PathwayKEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47495
PathwayKEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47496
PathwayKEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47497
PathwayKEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47472
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47535
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.21e-0315492M47531
PathwayREACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY

CREBBP EP300

1.21e-0315492M953
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1

PHC3 SMARCC1 ARID1A CREBBP EP300

1.34e-03237495M27786
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.38e-0316492M47363
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.38e-0316492M47373
PathwayKEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.38e-0316492M47381
PathwayREACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS

CREBBP EP300

1.38e-0316492M27121
PathwayKEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.38e-0316492M47804
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC17 MUC6

1.38e-0316492M27410
PathwayBIOCARTA_IL7_PATHWAY

CREBBP EP300

1.38e-0316492M1296
PathwayBIOCARTA_IL7_PATHWAY

CREBBP EP300

1.38e-0316492MM1420
PathwayREACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS

PHC3 PCGF2

1.38e-0316492M27403
PathwayWP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER

SOS1 SOS2

1.38e-0316492M39882
PathwayKEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.38e-0316492M47483
PathwayBIOCARTA_PITX2_PATHWAY

CREBBP EP300

1.38e-0316492M8516
PathwayREACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES

CREBBP EP300

1.38e-0316492M27940
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC17 CREBBP MUC6 EP300

1.40e-03140494M27484
PathwayWP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA

ARID1A CREBBP EP300

1.48e-0365493M39682
PathwayPID_HDAC_CLASSI_PATHWAY

MTA2 CREBBP EP300

1.55e-0366493M101
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MTA2 PRR12 NCOA6 TNRC18 SYNJ1 KIF26A PER1 C15orf39 ARHGAP17 RIPOR1 MBD6 ARID1A MAST2 DNMBP ZBTB42 IL4R EP300 ANO8 MPRIP

1.69e-131105671935748872
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

MTA2 GPHN NCOA6 SYNJ1 AMOT PRRC2C SMARCC1 PTPN23 POGZ TAF6 ARID1A CREBBP EP300 MPRIP

2.30e-12549671438280479
Pubmed

Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

PRR12 IRF2BP2 NCOA6 TP63 SMARCC1 POGZ ARID1A EP300

4.33e-128367828794006
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

GPHN SRRM1 NES NCOA6 SYNJ1 AMOT PRRC2C MAP4K1 FMN2 ARHGAP17 MAP3K21 MAST2 DNMBP CSPP1 WNK4 MPRIP

6.00e-12861671636931259
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

MTA2 PHC3 NCOA6 PCGF2 SMARCC1 MBD6 ARID1A CREBBP EP300

2.11e-1115767930186101
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

PHC3 NCOA6 TNRC18 CUX2 AEBP1 ATXN2 MAP4K1 TP63 FAM186B WNK4 SOS1 SOS2

3.56e-11430671235044719
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

MTA2 GPHN IRF2BP2 SRRM1 SYNJ1 RBM33 WASF2 SMARCC1 FMN2 TAF6 ARID1A MPRIP

2.30e-10506671230890647
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

MTA2 PRR12 IRF2BP2 NCOA6 TNRC18 WIPF1 ATXN2 RBM33 PRRC2C SMARCC1 C15orf39 POGZ TAF6 ARID1A CREBBP EP300

2.32e-101103671634189442
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

PRR12 PHC3 TNRC18 SYNJ1 JAZF1 SMARCC1 C15orf39 POGZ ARID1A CREBBP EP300

2.78e-10398671135016035
Pubmed

Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.

PRR12 SRRM1 NCOA6 RBM33 AMOT SMARCC1 C15orf39 ARHGAP17 ARID1A CREBBP EP300

5.55e-10425671124999758
Pubmed

Human transcription factor protein interaction networks.

PRR12 IRF2BP2 PHC3 NCOA6 ATXN2 RBM33 PRRC2C SMARCC1 C15orf39 ZC3H18 POGZ TAF6 MBD6 ARID1A CREBBP EP300 MPRIP

1.19e-091429671735140242
Pubmed

Interaction network of human early embryonic transcription factors.

PRR12 NCOA6 TNRC18 SMARCC1 C15orf39 POGZ MBD6 ARID1A CREBBP EP300

1.44e-09351671038297188
Pubmed

A human MAP kinase interactome.

WIPF1 KIF26A RBM33 PTPN23 ARHGAP17 POGZ MAP3K21 CREBBP EP300 SOS1 SOS2

2.25e-09486671120936779
Pubmed

Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.

IRF2BP2 SMARCC1 ARID1A CREBBP EP300

1.42e-084067534585037
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

PRR12 IRF2BP2 NCOA6 ATXN2 RBM33 PRRC2C SMARCC1 ARID1A CREBBP EP300

1.77e-08457671032344865
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MTA2 SRRM1 PER1 JAZF1 SMARCC1 FMN2 ZC3H18 POGZ TAF6 ARID1A MAST2 CREBBP EP300 SOS1

2.27e-081116671431753913
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

IRF2BP2 SRRM1 PHC3 NCOA6 MAP4K1 SMARCC1 RIPOR1 ZC3H18 POGZ TAF6 DNMBP SOS1

2.65e-08774671215302935
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

PRR12 IRF2BP2 NCOA6 TNRC18 RBM33 SMARCC1 ARID1A CREBBP

4.93e-0826867833640491
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

MTA2 SRRM1 SMARCC1 ZC3H18 POGZ TAF6

5.02e-0810367632744500
Pubmed

Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

MTA2 IRF2BP2 SMARCC1 POGZ ARID1A CREBBP EP300

5.49e-0817867727637333
Pubmed

Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

IRF2BP2 SRRM1 WIPF1 SYNJ1 ATXN2 ARHGAP17

6.67e-0810867619531213
Pubmed

Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.

NCOA6 CREBBP EP300

6.81e-08567311912212
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

MTA2 GPHN IRF2BP2 SRRM1 ATXN2 RBM33 AMOT PRRC2C SMARCC1

7.48e-0839967935987950
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

PCGF2 SYNJ1 MICAL2 MAST1 FMN2 POGZ TAF6 ARID1A CPNE5 CREBBP EP300 MPRIP SOS1 SOS2

1.29e-071285671435914814
Pubmed

Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock.

PER1 CREBBP EP300

1.36e-07667320930143
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

SYNJ1 RBM33 PRRC2C C15orf39 ARHGAP17 ZC3H18 ARID1A DNMBP CREBBP MPRIP

1.85e-07588671038580884
Pubmed

Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.

SMARCC1 CREBBP EP300

2.38e-0776739590696
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

IRF2BP2 TNRC18 PRRC2C WASF2 ARID1A CREBBP EP300 MPRIP

2.53e-0733267837433992
Pubmed

Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

IRF2BP2 NCOA6 SMARCC1 POGZ ARID1A

4.32e-077867528611094
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

PRR12 RBM33 AMOT C15orf39 CREBBP EP300

5.05e-0715267638360978
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

SRRM1 PHC3 PCGF2 RBM33 SMARCC1 ZC3H18 POGZ TAF6 ARID1A

8.47e-0753367930554943
Pubmed

Histone posttranslational modifications and cell fate determination: lens induction requires the lysine acetyltransferases CBP and p300.

TP63 CREBBP EP300

1.12e-061167324038357
Pubmed

Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.

SMARCC1 ARID1A CREBBP

1.12e-061167318003620
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

GPHN SRRM1 NES PRR36 RBM33 SMARCC1 ARHGAP17 DNMBP MPRIP SOS1 SOS2

1.33e-06916671132203420
Pubmed

Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.

NCOA6 CREBBP EP300

1.48e-061267312189208
Pubmed

Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.

PER1 CREBBP EP300

1.48e-061267314645221
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

SRRM1 PHC3 NCOA6 ATXN2 RBM33 PRRC2C SMARCC1 ZC3H18 POGZ TAF6 ARID1A

1.97e-06954671136373674
Pubmed

Loss of p300 accelerates MDS-associated leukemogenesis.

CREBBP EP300

3.66e-06267227881875
Pubmed

Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.

CREBBP EP300

3.66e-06267234845315
Pubmed

p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.

CREBBP EP300

3.66e-06267219729597
Pubmed

Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.

CREBBP EP300

3.66e-06267215860545
Pubmed

Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.

CREBBP EP300

3.66e-06267229460469
Pubmed

Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.

CREBBP EP300

3.66e-06267224551300
Pubmed

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.

CREBBP EP300

3.66e-06267233911074
Pubmed

The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.

CREBBP EP300

3.66e-0626729018065
Pubmed

Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.

CREBBP EP300

3.66e-06267224648406
Pubmed

CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.

CREBBP EP300

3.66e-06267230135524
Pubmed

CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.

CREBBP EP300

3.66e-06267239287984
Pubmed

Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.

CREBBP EP300

3.66e-06267216596650
Pubmed

The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.

CREBBP EP300

3.66e-06267229217654
Pubmed

Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.

CREBBP EP300

3.66e-06267220717166
Pubmed

Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.

CREBBP EP300

3.66e-06267210049825
Pubmed

CBP/p300 acetyltransferase activity in hematologic malignancies.

CREBBP EP300

3.66e-06267227380996
Pubmed

CREBBP and p300 lysine acetyl transferases in the DNA damage response.

CREBBP EP300

3.66e-06267229170789
Pubmed

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

CREBBP EP300

3.66e-06267225893291
Pubmed

A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17.

SOS1 SOS2

3.66e-0626728307589
Pubmed

Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

CREBBP EP300

3.66e-06267211559821
Pubmed

Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.

CREBBP EP300

3.66e-06267221555743
Pubmed

CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.

CREBBP EP300

3.66e-06267212646247
Pubmed

CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.

CREBBP EP300

3.66e-06267232576962
Pubmed

Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.

CREBBP EP300

3.66e-06267219822209
Pubmed

A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.

CREBBP EP300

3.66e-06267224522976
Pubmed

Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice.

CREBBP EP300

3.66e-06267211867645
Pubmed

CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.

CREBBP EP300

3.66e-06267221847097
Pubmed

Absence of both Sos-1 and Sos-2 in peripheral CD4(+) T cells leads to PI3K pathway activation and defects in migration.

SOS1 SOS2

3.66e-06267225973715
Pubmed

Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue.

CREBBP EP300

3.66e-06267211963968
Pubmed

Antisense-induced knockdown of cAMP response element-binding protein downregulates Per1 gene expression in the shell region of nucleus accumbens resulting in reduced alcohol consumption in mice.

PER1 CREBBP

3.66e-06267234424532
Pubmed

p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.

CREBBP EP300

3.66e-06267234813504
Pubmed

Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300.

CREBBP EP300

3.66e-0626729528808
Pubmed

Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines.

CREBBP EP300

3.66e-06267212696060
Pubmed

Rubinstein-Taybi Syndrome

CREBBP EP300

3.66e-06267220301699
Pubmed

CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain.

CREBBP EP300

3.66e-06267236109165
Pubmed

Potential biomarker of metformin action.

CREBBP EP300

3.66e-06267224639469
Pubmed

The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.

CREBBP EP300

3.66e-06267237816914
Pubmed

Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.

CREBBP EP300

3.66e-06267212242694
Pubmed

Binding of p300/CBP co-activators by polyoma large T antigen.

CREBBP EP300

3.66e-06267211438528
Pubmed

Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.

CREBBP EP300

3.66e-06267210918613
Pubmed

CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms.

CREBBP EP300

3.66e-06267231182547
Pubmed

Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras.

SOS1 SOS2

3.66e-0626721631150
Pubmed

Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.

CREBBP EP300

3.66e-06267235502657
Pubmed

Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report.

CREBBP EP300

3.66e-06267230635043
Pubmed

p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.

CREBBP EP300

3.66e-06267231898871
Pubmed

Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.

CREBBP EP300

3.66e-06267227648933
Pubmed

SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.

SOS1 SOS2

3.66e-06267234205562
Pubmed

Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.

CREBBP EP300

3.66e-06267230888860
Pubmed

Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.

CREBBP EP300

3.66e-06267227881443
Pubmed

Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.

CREBBP EP300

3.66e-06267219272189
Pubmed

Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis.

CREBBP EP300

3.66e-06267210610021
Pubmed

Emerging roles of p300/CBP in autophagy and autophagy-related human disorders.

CREBBP EP300

3.66e-06267237314181
Pubmed

The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1.

SOS1 SOS2

3.66e-0626729372945
Pubmed

Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.

CREBBP EP300

3.66e-06267212397173
Pubmed

CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.

CREBBP EP300

3.66e-06267215641773
Pubmed

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.

CREBBP EP300

3.66e-06267232690000
Pubmed

Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.

CREBBP EP300

3.66e-0626729733868
Pubmed

CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.

CREBBP EP300

3.66e-06267230953353
Pubmed

Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.

CREBBP EP300

3.66e-06267221803292
Pubmed

HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.

CREBBP EP300

3.66e-0626729811832
Pubmed

Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.

CREBBP EP300

3.66e-06267224089570
Pubmed

Rubinstein-Taybi syndrome in Chinese population with four novel mutations.

CREBBP EP300

3.66e-06267233063428
Pubmed

P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth.

MTA2 EP300

3.66e-06267224468085
InteractionSH3KBP1 interactions

MTA2 IRF2BP2 SRRM1 CD2 TNRC18 WIPF1 SYNJ1 ATXN2 TP63 ARHGAP17 TAF6 DNMBP SOS1

2.06e-113156513int:SH3KBP1
InteractionWWTR1 interactions

MTA2 GPHN NCOA6 SYNJ1 AMOT PRRC2C TP63 SMARCC1 PTPN23 POGZ ARID1A CREBBP EP300 MPRIP

5.81e-114226514int:WWTR1
InteractionTOP3B interactions

MTA2 PRR12 NCOA6 TNRC18 SYNJ1 ATXN2 KIF26A RBM33 PER1 C15orf39 ARHGAP17 RIPOR1 MBD6 ARID1A MAST2 DNMBP ZBTB42 IL4R EP300 ANO8 MPRIP

3.10e-0914706521int:TOP3B
InteractionTBXT interactions

PRR12 IRF2BP2 NCOA6 SMARCC1 POGZ ARID1A CREBBP EP300

3.62e-09116658int:TBXT
InteractionEGR2 interactions

PRR12 NCOA6 TNRC18 SMARCC1 C15orf39 POGZ ARID1A CREBBP EP300

3.93e-09171659int:EGR2
InteractionSOX7 interactions

PRR12 TNRC18 SMARCC1 C15orf39 ARID1A CREBBP EP300

8.19e-0982657int:SOX7
InteractionFEV interactions

PRR12 PHC3 NCOA6 C15orf39 POGZ TAF6 ARID1A CREBBP EP300

1.76e-08203659int:FEV
InteractionSOX9 interactions

PRR12 PHC3 NCOA6 SMARCC1 ARID1A CREBBP EP300

2.66e-0897657int:SOX9
InteractionACTC1 interactions

MTA2 GPHN IRF2BP2 SRRM1 WIPF1 SYNJ1 RBM33 WASF2 JAZF1 SMARCC1 FMN2 TAF6 ARID1A MPRIP

3.47e-086946514int:ACTC1
InteractionPACSIN1 interactions

WIPF1 SYNJ1 WASF2 ARHGAP17 MPRIP SOS1

3.88e-0860656int:PACSIN1
InteractionSP7 interactions

PRR12 IRF2BP2 NCOA6 RBM33 SMARCC1 C15orf39 POGZ ARID1A CREBBP EP300

4.53e-083046510int:SP7
InteractionHNF4A interactions

PRR12 IRF2BP2 NCOA6 SMARCC1 POGZ TAF6 ARID1A CREBBP EP300

2.36e-07275659int:HNF4A
InteractionPAX6 interactions

PRR12 IRF2BP2 NCOA6 SYNJ1 SMARCC1 POGZ TAF6 ARID1A CREBBP EP300

2.54e-073666510int:PAX6
InteractionYWHAH interactions

SRRM1 NES NCOA6 SYNJ1 AMOT PRRC2C WASF2 MAST1 FMN2 ARHGAP17 MAP3K21 MAST2 DNMBP CSPP1 CREBBP MPRIP

2.94e-0711026516int:YWHAH
InteractionVASP interactions

GPHN IRF2BP2 SYNJ1 AEBP1 AMOT WASF2 FMN2 PTPN23 DNMBP

4.14e-07294659int:VASP
InteractionNUP35 interactions

PRR12 IRF2BP2 NCOA6 ATXN2 RBM33 PRRC2C SMARCC1 ARID1A CREBBP EP300

9.74e-074246510int:NUP35
InteractionTPRX2 interactions

PRR12 NCOA6 SMARCC1 ARID1A CREBBP

1.00e-0656655int:TPRX2
InteractionGRB2 interactions

WIPF1 SYNJ1 AEBP1 RBM33 MAP4K1 TP63 WASF2 PTPN23 ARHGAP17 EP300 SOCS7 SOS1 SOS2

1.46e-068066513int:GRB2
InteractionCEBPA interactions

MTA2 PRR12 IRF2BP2 NCOA6 TNRC18 WIPF1 ATXN2 RBM33 PRRC2C SMARCC1 C15orf39 POGZ TAF6 ARID1A CREBBP EP300

1.49e-0612456516int:CEBPA
InteractionTLX1 interactions

PRR12 IRF2BP2 SMARCC1 POGZ ARID1A CREBBP EP300

1.50e-06175657int:TLX1
InteractionCRX interactions

PRR12 TNRC18 SMARCC1 C15orf39 POGZ ARID1A CREBBP EP300

1.55e-06254658int:CRX
InteractionNCK2 interactions

WIPF1 MAP4K1 WASF2 MBD6 CPNE5 ZBTB42 SOCS7 SOS1

1.95e-06262658int:NCK2
InteractionALG13 interactions

PRR12 ATXN2 RBM33 PRRC2C C15orf39 ARID1A EP300

2.03e-06183657int:ALG13
InteractionHNF1B interactions

PRR12 SMARCC1 POGZ MBD6 ARID1A CREBBP EP300

2.60e-06190657int:HNF1B
InteractionGCM1 interactions

PRR12 SMARCC1 ARID1A CREBBP EP300

2.66e-0668655int:GCM1
InteractionETV4 interactions

PRR12 TP63 ARID1A CREBBP EP300

2.86e-0669655int:ETV4
InteractionKLF5 interactions

MTA2 PRR12 NCOA6 TP63 ARID1A CREBBP EP300

3.09e-06195657int:KLF5
InteractionNFATC2 interactions

MTA2 IRF2BP2 SMARCC1 POGZ ARID1A CREBBP EP300

3.65e-06200657int:NFATC2
InteractionBAG2 interactions

IRF2BP2 PHC3 NCOA6 RBM33 AMOT PRRC2C C15orf39 PTPN23 ARHGAP17 CREBBP EP300

4.37e-066226511int:BAG2
InteractionCSNK2B interactions

MTA2 SRRM1 PCGF2 MAP4K1 TP63 PER1 MAST1 ZC3H18 POGZ CREBBP EP300

4.57e-066256511int:CSNK2B
InteractionEWSR1 interactions

PRR12 SRRM1 NCOA6 RBM33 AMOT PER1 SMARCC1 C15orf39 ARHGAP17 ZC3H18 ARID1A CREBBP EP300

5.26e-069066513int:EWSR1
InteractionKLF1 interactions

SMARCC1 ARID1A CREBBP EP300

6.01e-0637654int:KLF1
InteractionERG interactions

PRR12 NCOA6 SMARCC1 C15orf39 ARID1A CREBBP EP300

7.46e-06223657int:ERG
InteractionYWHAG interactions

GPHN SRRM1 NCOA6 TTBK1 SYNJ1 AMOT PRRC2C WASF2 FMN2 ARHGAP17 MAP3K21 MAST2 DNMBP CSPP1 MPRIP

7.65e-0612486515int:YWHAG
InteractionFOXK2 interactions

MTA2 AMOT PRRC2C TP63 PER1 MBD6 EP300

7.91e-06225657int:FOXK2
InteractionYAP1 interactions

MTA2 GPHN NCOA6 TNRC18 AMOT PRRC2C TP63 SMARCC1 POGZ TAF6 ARID1A CREBBP EP300 MPRIP

8.13e-0610956514int:YAP1
InteractionSMG7 interactions

PRR12 IRF2BP2 NCOA6 ATXN2 RBM33 AMOT ARID1A CREBBP

8.32e-06319658int:SMG7
InteractionSNX9 interactions

SYNJ1 CPNE5 DNMBP EP300 SOS1 SOS2

8.85e-06150656int:SNX9
InteractionGSC interactions

PRR12 TNRC18 C15orf39 CREBBP EP300

8.99e-0687655int:GSC
InteractionEYA4 interactions

GPHN PRR12 RBM33 AMOT C15orf39 CREBBP EP300

1.30e-05243657int:EYA4
InteractionNCK1 interactions

WIPF1 MAP4K1 WASF2 CPNE5 SOCS7 SOS1 SOS2

1.34e-05244657int:NCK1
InteractionASF1A interactions

MTA2 IRF2BP2 NCOA6 SMARCC1 POGZ ARID1A EP300

1.53e-05249657int:ASF1A
InteractionSAP30 interactions

MTA2 PHC3 TNRC18 SMARCC1 TAF6 ARID1A

1.63e-05167656int:SAP30
InteractionLCK interactions

CD2 SYNJ1 AMOT FMN2 ARHGAP17 MAP3K21 EP300 MPRIP SOS1

1.69e-05463659int:LCK
InteractionING1 interactions

TNRC18 SMARCC1 ARID1A CREBBP EP300

2.05e-05103655int:ING1
InteractionTEAD1 interactions

PRR12 IRF2BP2 TP63 ARID1A CREBBP EP300

2.20e-05176656int:TEAD1
InteractionNFYA interactions

TP63 POGZ TAF6 CREBBP EP300

2.25e-05105655int:NFYA
InteractionTLE3 interactions

PRR12 IRF2BP2 PHC3 TNRC18 C15orf39 ARID1A CREBBP EP300

2.72e-05376658int:TLE3
InteractionCLTB interactions

GPHN NES SYNJ1 PTPN23 MAP3K21 DNMBP

2.91e-05185656int:CLTB
InteractionSIN3A interactions

MTA2 IRF2BP2 PER1 SMARCC1 TAF6 ARID1A CREBBP EP300

2.93e-05380658int:SIN3A
InteractionNUP43 interactions

MTA2 SRRM1 PHC3 NCOA6 PRRC2C SMARCC1 ZC3H18 POGZ TAF6 ARID1A

2.95e-056256510int:NUP43
InteractionNEUROG1 interactions

NES CREBBP EP300

2.99e-0519653int:NEUROG1
InteractionMEX3A interactions

IRF2BP2 TNRC18 PRRC2C WASF2 ARID1A CREBBP EP300 MPRIP

3.16e-05384658int:MEX3A
InteractionPFN1 interactions

GPHN SYNJ1 TP63 WASF2 FMN2 ARHGAP17 ZC3H18 DNMBP MPRIP

3.54e-05509659int:PFN1
InteractionRBBP5 interactions

MTA2 NCOA6 SMARCC1 TAF6 ARID1A CREBBP EP300

3.79e-05287657int:RBBP5
InteractionMYOD1 interactions

PRR12 SMARCC1 TAF6 ARID1A CREBBP EP300

3.79e-05194656int:MYOD1
InteractionTLX3 interactions

PRR12 NCOA6 PER1 C15orf39 POGZ ARID1A EP300

4.14e-05291657int:TLX3
InteractionGATA2 interactions

PRR12 NCOA6 SMARCC1 ARID1A CREBBP EP300

4.37e-05199656int:GATA2
InteractionETS1 interactions

SMARCC1 TAF6 ARID1A CREBBP EP300

4.45e-05121655int:ETS1
InteractionFUBP3 interactions

ATXN2 RBM33 PRRC2C SMARCC1 ZC3H18 EP300 SOS2

4.71e-05297657int:FUBP3
InteractionCSNK2A1 interactions

MTA2 SRRM1 CUX2 PCGF2 ATXN2 RBM33 PRRC2C TP63 MAST1 ZC3H18 CREBBP EP300

4.77e-059566512int:CSNK2A1
InteractionSAP18 interactions

MTA2 SRRM1 RBM33 SMARCC1 ZC3H18 ARID1A SOS2

5.58e-05305657int:SAP18
InteractionDEK interactions

IRF2BP2 SRRM1 SMARCC1 ZC3H18 CREBBP EP300

5.75e-05209656int:DEK
InteractionPAX9 interactions

PRR12 NCOA6 C15orf39 ARID1A EP300

6.26e-05130655int:PAX9
InteractionPACSIN3 interactions

WIPF1 SYNJ1 MPRIP SOS1 SOS2

6.50e-05131655int:PACSIN3
InteractionJPH4 interactions

MICAL2 PRRC2C ZC3H18 MPRIP

6.87e-0568654int:JPH4
InteractionSFN interactions

NCOA6 AMOT PRRC2C TP63 FMN2 ZC3H18 MAP3K21 MAST2 DNMBP MPRIP

6.94e-056926510int:SFN
InteractionH2BC21 interactions

MTA2 PRR12 PCGF2 MAP4K1 SMARCC1 ZC3H18 POGZ ARID1A CREBBP EP300

7.28e-056966510int:H2BC21
InteractionKLF8 interactions

PRR12 PRRC2C TP63 POGZ TAF6 CREBBP EP300

8.96e-05329657int:KLF8
InteractionNFIX interactions

PRR12 IRF2BP2 SMARCC1 POGZ TAF6 ARID1A

9.07e-05227656int:NFIX
InteractionHDAC2 interactions

MTA2 IRF2BP2 PODXL PRRC2C TP63 SMARCC1 ZC3H18 TAF6 ARID1A CREBBP EP300

9.16e-058656511int:HDAC2
InteractionCSNK2A2 interactions

MTA2 SRRM1 PHC3 PCGF2 PRRC2C TP63 MAST1 ZC3H18 CREBBP EP300

9.42e-057186510int:CSNK2A2
InteractionYY1 interactions

MTA2 PHC3 PCGF2 POGZ TAF6 MBD6 CREBBP EP300

1.02e-04454658int:YY1
InteractionNCOA1 interactions

NCOA6 SMARCC1 ARID1A CREBBP EP300

1.08e-04146655int:NCOA1
InteractionSMARCA2 interactions

MTA2 SMARCC1 TAF6 ARID1A CREBBP EP300 MPRIP

1.23e-04346657int:SMARCA2
InteractionBRDT interactions

SRRM1 RBM33 SMARCC1 TAF6

1.36e-0481654int:BRDT
InteractionSMARCC2 interactions

MTA2 SRRM1 SMARCC1 TAF6 ARID1A CREBBP EP300

1.39e-04353657int:SMARCC2
InteractionACTB interactions

MTA2 ATXN2 PODXL AMOT WASF2 SMARCC1 FMN2 ARHGAP17 ARID1A CREBBP EP300 MPRIP

1.56e-0410836512int:ACTB
InteractionABL1 interactions

MAP4K1 WASF2 ARHGAP17 EP300 SOS1 SOS2

1.86e-04259656int:ABL1
InteractionSH3GL2 interactions

SYNJ1 ATXN2 PTPN23 MAST2

1.88e-0488654int:SH3GL2
InteractionKHDRBS1 interactions

MTA2 GPHN SRRM1 ATXN2 DNMBP CREBBP EP300

1.95e-04373657int:KHDRBS1
InteractionN4BP2 interactions

AMOT TP63 CREBBP EP300

1.96e-0489654int:N4BP2
InteractionDYNLL2 interactions

GPHN NCOA6 AMOT MAST1 ZC3H18 POGZ

2.02e-04263656int:DYNLL2
InteractionE2F5 interactions

ARID1A CREBBP EP300

2.12e-0436653int:E2F5
InteractionRBBP7 interactions

MTA2 TNRC18 SMARCC1 ZC3H18 TAF6 ARID1A CREBBP EP300

2.18e-04507658int:RBBP7
InteractionSETD1A interactions

MTA2 NCOA6 TAF6 CREBBP EP300

2.21e-04170655int:SETD1A
InteractionFOXI1 interactions

PRR12 ARID1A CREBBP EP300

2.23e-0492654int:FOXI1
InteractionSPAG9 interactions

MTA2 PODXL MAP4K1 SMARCC1 TAF6 EP300

2.24e-04268656int:SPAG9
InteractionGATA1 interactions

MTA2 SMARCC1 ARID1A CREBBP EP300

2.27e-04171655int:GATA1
InteractionPIN1 interactions

GPHN SRRM1 SSC5D AMOT TP63 ZBTB42 EP300

2.29e-04383657int:PIN1
InteractionSMAD2 interactions

MTA2 NCOA6 SMARCC1 TAF6 ARID1A CREBBP EP300

2.36e-04385657int:SMAD2
InteractionACTG1 interactions

GPHN WIPF1 AMOT WASF2 SMARCC1 FMN2 ZC3H18 ARID1A

2.58e-04520658int:ACTG1
InteractionFHL2 interactions

PHC3 TNRC18 AMOT PRRC2C POGZ CREBBP EP300

2.80e-04396657int:FHL2
InteractionSS18L1 interactions

SMARCC1 ARID1A CREBBP EP300

2.84e-0498654int:SS18L1
InteractionTFCP2L1 interactions

MTA2 SMARCC1 POGZ ARID1A

2.95e-0499654int:TFCP2L1
InteractionBZW1 interactions

MTA2 SRRM1 SMARCC1 TAF6 EP300

3.11e-04183655int:BZW1
InteractionTFF1 interactions

CREBBP MUC6 EP300

3.13e-0441653int:TFF1
InteractionSMC5 interactions

SRRM1 PHC3 NCOA6 ATXN2 RBM33 PRRC2C SMARCC1 ZC3H18 POGZ TAF6 ARID1A

3.24e-0410006511int:SMC5
InteractionACTL6A interactions

MTA2 SMARCC1 ZC3H18 TAF6 ARID1A EP300

3.35e-04289656int:ACTL6A
InteractionKLF15 interactions

PRR12 PRRC2C POGZ TAF6 CREBBP EP300

3.42e-04290656int:KLF15
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

DNMBP SOS1 SOS2

5.17e-0466433722
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

CREBBP EP300

7.35e-0417432486
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

CREBBP EP300

8.25e-041843291
GeneFamilyCD molecules|Mucins

MUC17 MUC6

1.13e-0321432648
GeneFamilyAtaxins|Trinucleotide repeat containing

TNRC18 ATXN2

1.60e-0325432775
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

PRRC2C ARID1A MAST2 CREBBP EP300 SOS1

6.80e-06180676M8239
CoexpressionQI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE

MMP25 IRF2BP2 NCOA6 RBM33 RIPOR1 ARID1A CREBBP

1.02e-05294677M40873
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

SMARCC1 PTPN23 ARID1A MAP3K21 FAM186B

5.17e-0616667532d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCellRV-17._Lymphocyte|RV / Chamber and Cluster_Paper

MMP25 CD2 WIPF1 MAP4K1

8.34e-05153674e1ea621184014415870e00d511386b8cc3e0833b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AEBP1 MICAL2 TP63 FMN2

8.99e-05156674dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AEBP1 MICAL2 TP63 FMN2

8.99e-05156674abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue

VGF AEBP1 KIF26A RIPOR1

8.99e-05156674b093dbba6662e4fffc8aa577587b77f64ac44b56
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CUX2 CPNE5 FAM186B IL4R

9.92e-05160674fe9970c160159b35f6599ed13c89cfb49264d554
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

CD2 MAP4K1 PER1 JAZF1

1.17e-04167674c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells)

CD2 TNRC18 CSPP1 SOS1

1.20e-041686742781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.20e-04168674fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.20e-04168674315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.25e-0417067460bbd738c12e64e483485586c30057304884f5a6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.31e-041726746c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.31e-04172674381ae1c3c07d0a424f43455ec571653b192a946a
ToppCellcritical-Myeloid-pDC|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CUX2 AEBP1 C11orf24 CPNE5

1.34e-04173674e8508c3efbe0f0fae51484a5535d43103c810d4e
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VGF CUX2 PRR36 MAP4K1

1.37e-041746744120656e6d6cf5435a248326b5fdbdc7b22137af
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.37e-04174674dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.46e-041776744d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 NES PRRC2C WASF2

1.49e-0417867401dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 MAP4K1 MAST1 CPNE5

1.49e-04178674ba5a477257877f4a15a91c1762ffcc6f2e9f7357
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 MAP4K1 MAST1 CPNE5

1.49e-041786745634c1fbc817758092af4feafff94d107412d89b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.49e-04178674edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCellfacs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 MAP4K1 JAZF1 IL4R

1.53e-04179674f4fd214a9865c635d8a744ce5e0eff45174d3de4
ToppCellfacs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 MAP4K1 JAZF1 IL4R

1.53e-0417967457d8d44a793314eec8f77030f4177bfe21d41652
ToppCellnormal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass

CD2 WIPF1 MICAL2 WNK4

1.53e-041796743dc929a10381b7d86650c6cd8f354892fe1d93e7
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF26A PODXL RIPOR1 IL4R

1.56e-041806742405aa5699a8d8cf4c6b3dca07510e774728ac50
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.56e-04180674d685fa2b013bc085dbef7c40956ed3043f83e483
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF26A PODXL RIPOR1 IL4R

1.56e-041806749c47852c0a723e2f5cd6898afff4c31a0da06905
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF26A PODXL RIPOR1 IL4R

1.56e-04180674499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.63e-04182674cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCellCOVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type

NES PODXL FMN2 RIPOR1

1.66e-04183674fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.66e-04183674612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.66e-04183674848fc6dd129150897ee339343e83c645b6e779eb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.66e-041836747c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C WASF2 SMARCC1 EP300

1.70e-041846741154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.73e-041856749197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

AEBP1 MICAL2 TP63 FMN2

1.73e-0418567434fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.73e-04185674ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.73e-04185674b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

AEBP1 MICAL2 TP63 FMN2

1.73e-041856748816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.77e-041866741094c7140131454b2583200e1c01e81ccab3db23
ToppCell356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells)

NES PCGF2 KIF26A PODXL

1.77e-041866742e024097ee361eeb1d855a4edb8ac8cdad35da06
ToppCell356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells)

NES PCGF2 KIF26A PODXL

1.77e-04186674c3449e54454009973818fc1101933c6f0168258c
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

PHC3 CREBBP EP300 SOS1

1.77e-0418667403db813598b67b1e08f759758a1c2023396921fa
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VGF CD2 MAST1 CPNE5

1.77e-041866747278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM1 PRRC2C WASF2 CREBBP

1.81e-04187674663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.81e-0418767424c2a3962da364e46e98abeab5f8234376fa26bb
ToppCellfacs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NES KIF26A PODXL RIPOR1

1.84e-04188674ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.84e-041886749db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCellfacs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NES KIF26A PODXL RIPOR1

1.84e-04188674e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SYNJ1 PRR36 MAST1 CPNE5

1.84e-04188674b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCellfacs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NES KIF26A PODXL RIPOR1

1.84e-041886740fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.84e-04188674047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

1.92e-0419067492710caaff05123cf8e909319d7ac441d9b31a66
ToppCellBLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CD2 CUX2 AEBP1 MAP4K1

1.92e-041906749b8de47f7a2e6137d934ccce32417ab15eb54f46
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NES KIF26A PODXL SOS1

1.96e-0419167404c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NES KIF26A PODXL SOS1

1.96e-04191674db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

2.00e-04192674ef0aba777072429a6ab7dcfcc305673975946580
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES PODXL FMN2 RIPOR1

2.04e-041936743eaa0461618582a1754400624350d269d24e750a
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NES KIF26A PODXL SOS1

2.04e-041936743a9fe4e709c09ec787c71bdd6b58a71c419896de
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

ATXN2 RBM33 PRRC2C SOS1

2.04e-04193674e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellfacs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTA2 PRRC2C RIPOR1 MPRIP

2.08e-04194674f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCellfacs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTA2 PRRC2C RIPOR1 MPRIP

2.08e-04194674cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCellfacs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MTA2 PRRC2C RIPOR1 MPRIP

2.08e-0419467466c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF2BP2 SYNJ1 PRRC2C FMN2

2.12e-041956743e519cffa6144a62b06124642a14c9ff39b76554
ToppCellMS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class

TP63 C11orf24 CPNE5 FAM186B

2.20e-041976741b5ac53297cc557e08b9e8e511c2385a38f56bd6
ToppCellmLN-T_cell-Th17|mLN / Region, Cell class and subclass

IRF2BP2 CD2 MUC17 PER1

2.25e-0419867404905f62941b193864704a10ad692faf777fa51d
ToppCellmLN-(1)_T_cell-(13)_Th17|mLN / shred on region, Cell_type, and subtype

IRF2BP2 CD2 MUC17 PER1

2.25e-04198674c575e9aeee4e034e8c4d171fe754403652343731
ToppCellmedial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

NES PRRC2C WASF2 IL4R

2.25e-04198674071658de0c43f302172692aa0b4b507dbad7be50
ToppCellsevere-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

MMP25 CPNE5 IL4R SOS2

2.29e-0419967450242666def13e5d4149c563ae000d6768f086f7
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 WIPF1 MAP4K1 JAZF1

2.29e-04199674eb188b0b457136b6ee485d3b3052baa30d9c0002
ToppCell11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

NES SSC5D AEBP1 WFIKKN2

2.29e-041996741a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCellsevere-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

MMP25 CPNE5 IL4R SOS2

2.33e-04200674b665f36dcf3c9d3981ee96f2973512f751612542
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

WIPF1 PRRC2C PER1 MBD6

2.33e-042006740d76b006d8e8b32174e65e400acd0674354b962c
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

WIPF1 PRRC2C PER1 MBD6

2.33e-04200674cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
DrugFluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A

PHC3 PRR36 PER1 C15orf39 CSPP1 IL4R SOS1 SOS2

9.79e-081966687348_DN
DrugDoxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A

MTA2 WIPF1 SMARCC1 ARID1A DNMBP CSPP1 SOS2

1.49e-061946676642_DN
DrugTorsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A

MTA2 PCGF2 WIPF1 SYNJ1 PER1 ARID1A MAST2

1.77e-061996675057_DN
DrugCefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A

PHC3 PCGF2 SYNJ1 PER1 CSPP1 IL4R

2.23e-051966662843_DN
Drug2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A

VGF PHC3 PCGF2 WIPF1 SYNJ1 MAST2

2.23e-051966664446_DN
DrugDinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

VGF NES PHC3 PCGF2 PRR36 MICAL2

2.29e-051976663308_DN
Drug3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide

CREBBP EP300

8.23e-055662ctd:C575894
DrugAl 6629

GPHN PHC3 PER1 SOS1 SOS2

1.11e-04163665CID004369171
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

PHC3 PCGF2 RIPOR1 ARID1A CREBBP

1.35e-041706653791_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

NCOA6 PCGF2 ARID1A CREBBP EP300

1.43e-041726651072_DN
DrugParthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A

SYNJ1 MICAL2 PER1 MUC6 SOS1

1.47e-041736655105_UP
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

NCOA6 PCGF2 ARID1A CREBBP EP300

1.55e-041756651014_DN
DrugSAHA; Down 200; 10uM; PC3; HT_HG-U133A

MTA2 ARID1A CREBBP IL4R EP300

1.68e-041786654444_DN
DrugTiNi

PER1 CREBBP IL4R EP300

2.05e-04100664CID000159408
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

PCGF2 C15orf39 RIPOR1 MAST2 DNMBP

2.22e-041896651651_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

MTA2 PHC3 MAST2 EP300 SOS2

2.22e-041896655084_DN
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A

GPHN SYNJ1 PER1 TRAK2 DNMBP

2.27e-041906655855_DN
Drug17-AAG; Down 200; 1uM; ssMCF7; HG-U133A

C15orf39 RIPOR1 C11orf24 CSPP1 IL4R

2.33e-04191665521_DN
Drugetheno-NAD

WIPF1 WASF2 DNMBP SOS1

2.38e-04104664CID005288160
Drug17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A

PCGF2 MICAL2 C15orf39 RIPOR1 ARID1A

2.38e-041926651638_DN
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A

PCGF2 PRR36 MICAL2 RIPOR1 ARID1A

2.44e-041936651644_DN
DrugSTOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A

MTA2 PER1 DNMBP MUC6 SOS2

2.44e-041936656869_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

C15orf39 RIPOR1 MAST2 DNMBP CSPP1

2.44e-041936655566_DN
DrugDilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A

PCGF2 SMARCC1 RIPOR1 MAST2 EP300

2.44e-041936657364_DN
DrugCinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A

WIPF1 SYNJ1 MICAL2 TP63 SOS2

2.56e-041956654107_UP
DrugMiconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A

PHC3 WIPF1 AEBP1 PER1 SOS2

2.56e-041956654960_UP
Drugestradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A

PHC3 WIPF1 SYNJ1 TP63 SOS2

2.56e-041956655568_UP
DrugDroperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A

MMP25 PHC3 PRRC2C ARID1A MAST2

2.56e-041956651290_DN
DrugDiphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A

PHC3 PER1 RIPOR1 CSPP1 IL4R

2.62e-041966651708_DN
Drugtrichostatin A; Up 200; 0.1uM; ssMCF7; HG-U133A

WIPF1 AMOT MAP4K1 TP63 IL4R

2.62e-04196665413_UP
DrugMeropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A

MMP25 CUX2 WIPF1 ARID1A MUC6

2.62e-041966653564_UP
Drugretinoic acid; Down 200; 1uM; HL60; HG-U133A

PCGF2 MICAL2 TP63 RIPOR1 MAST2

2.62e-04196665390_DN
DrugClemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A

MTA2 PCGF2 SYNJ1 MAP4K1 PER1

2.62e-041966657371_UP
DrugBretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

VGF POGZ ARID1A MAST2 CSPP1

2.62e-041966655020_DN
Drugoligomycin; Down 200; 1uM; MCF7; HG-U133A

NES WIPF1 ATXN2 MAP4K1 EP300

2.62e-04196665442_DN
DrugLabetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A

PCGF2 PER1 CSPP1 SOCS7 SOS2

2.62e-041966653167_DN
DrugLisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A

PCGF2 MICAL2 PER1 C11orf24 CSPP1

2.62e-041966655504_DN
DrugNisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A

VGF MTA2 C15orf39 CSPP1 SOS2

2.62e-041966655091_DN
DrugThioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A

PHC3 WIPF1 SYNJ1 PRR36 MAST2

2.62e-041966652073_UP
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A

VGF PHC3 RIPOR1 ARID1A IL4R

2.69e-041976657197_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A

MTA2 PHC3 PRR36 PER1 C15orf39

2.69e-041976653862_DN
DrugProcainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A

PHC3 WIPF1 AMOT MUC6 SOS2

2.69e-041976652618_UP
DrugGlycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A

PCGF2 PER1 C15orf39 CSPP1 SOS2

2.69e-041976657386_DN
DrugMesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A

PCGF2 RIPOR1 C11orf24 MAST2 IL4R

2.69e-041976657241_DN
DrugKetoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A

PCGF2 PER1 RIPOR1 CSPP1 SOS2

2.69e-041976655685_DN
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A

VGF MTA2 MICAL2 SOS1 SOS2

2.69e-041976656999_DN
Drugalpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A

PRR36 C15orf39 RIPOR1 C11orf24 EP300

2.69e-041976651635_DN
DrugAzaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A

NES PCGF2 ARID1A MAST2 DNMBP

2.69e-041976657231_DN
DrugDemecarium bromide [56-94-0]; Up 200; 5.6uM; HL60; HG-U133A

PCGF2 SMARCC1 ARID1A MAST2 SOS2

2.69e-041976651781_UP
Drugbeta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A

MMP25 MTA2 PRR36 MUC6 SOCS7

2.69e-041976652819_UP
DrugPseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A

WIPF1 PRR36 RIPOR1 IL4R SOCS7

2.69e-041976652766_UP
Drugclozapine; Down 200; 10uM; HL60; HT_HG-U133A

PHC3 PCGF2 ATXN2 CSPP1 IL4R

2.75e-041986651170_DN
DrugEnalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A

RIPOR1 MAST2 CSPP1 EP300 SOS2

2.75e-041986657428_UP
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; MCF7; HG-U133A

PHC3 ATXN2 TP63 MAST2 IL4R

2.75e-04198665406_DN
DrugPronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A

MTA2 WIPF1 TP63 PER1 MUC6

2.75e-041986657322_UP
DrugStreptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A

CSPP1 MUC6 IL4R SOS1 SOS2

2.75e-041986655837_UP
DrugStreptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A

VGF C15orf39 ARID1A CSPP1 SOS2

2.75e-041986657193_DN
DrugFlunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A

MTA2 PCGF2 WIPF1 POGZ IL4R

2.75e-041986652381_DN
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A

PHC3 PRR36 MAST2 CSPP1 SOS2

2.75e-041986655243_DN
DrugTrimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A

MICAL2 MAST2 DNMBP CSPP1 IL4R

2.75e-041986657235_DN
Drugnordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A

MTA2 SYNJ1 TP63 MAST2 SOS2

2.75e-041986655220_UP
DrugPinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A

MICAL2 RIPOR1 ARID1A CSPP1 SOS2

2.75e-041986657437_UP
DrugEstradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A

MMP25 PHC3 PCGF2 CSPP1 SOS2

2.75e-041986651299_DN
DrugBufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A

PCGF2 SYNJ1 PRR36 PER1 SOS2

2.75e-041986655515_UP
DrugCP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A

VGF PHC3 SYNJ1 PRR36 RIPOR1

2.81e-041996654383_DN
DrugTropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A

MMP25 PODXL MAST2 MUC6 SOS1

2.81e-041996653569_UP
DrugDapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A

PRRC2C PER1 SMARCC1 POGZ EP300

2.81e-041996651705_UP
DrugNalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A

VGF TP63 ARID1A SOS1 SOS2

2.81e-041996655820_UP
DrugMetampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

PRR36 SMARCC1 RIPOR1 MAST2 IL4R

2.81e-041996655540_UP
DrugGuanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A

POGZ CSPP1 MPRIP SOS1 SOS2

2.81e-041996652045_DN
DrugWY-14643; Up 200; 100uM; PC3; HG-U133A

CD2 POGZ MAST2 MUC6 EP300

2.88e-04200665481_UP
DrugDeferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A

MMP25 AMOT MAP4K1 ARID1A SOS2

2.88e-042006653936_UP
DrugEpiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

VGF PCGF2 RIPOR1 CSPP1 SOS2

2.88e-042006655687_DN
DiseaseMenke-Hennekam syndrome

CREBBP EP300

5.08e-062672cv:C5681632
DiseaseRubinstein-Taybi syndrome (implicated_via_orthology)

CREBBP EP300

5.08e-062672DOID:1933 (implicated_via_orthology)
DiseaseRubinstein-Taybi syndrome

CREBBP EP300

5.08e-062672cv:C0035934
DiseaseRUBINSTEIN-TAYBI SYNDROME 1

CREBBP EP300

5.08e-062672C4551859
DiseaseRUBINSTEIN-TAYBI SYNDROME 1

CREBBP EP300

5.08e-062672180849
DiseaseRubinstein-Taybi syndrome due to CREBBP mutations

CREBBP EP300

5.08e-062672cv:C4551859
DiseaseRubinstein-Taybi syndrome (is_implicated_in)

CREBBP EP300

5.08e-062672DOID:1933 (is_implicated_in)
DiseaseRubinstein-Taybi Syndrome

CREBBP EP300

5.08e-062672C0035934
DiseaseMetastatic melanoma

TTBK1 MAP4K1 MAST1 WNK4

7.05e-0654674C0278883
DiseaseAtypical juvenile parkinsonism

SYNJ1 PODXL

1.52e-053672C4510873
Diseasehypertension

PHC3 CUX2 TTBK1 ATXN2 PODXL SOS2

7.07e-05307676EFO_0000537
Diseasealcohol use disorder (implicated_via_orthology)

MAP4K1 SMARCC1 ARID1A CREBBP EP300

8.29e-05195675DOID:1574 (implicated_via_orthology)
DiseaseAdenocarcinoma of lung (disorder)

TP63 SMARCC1 CREBBP EP300 SOS1

1.07e-04206675C0152013
DiseaseCarcinoma, Transitional Cell

ARID1A CREBBP EP300

1.12e-0441673C0007138
Diseaseserum non-albumin protein measurement

CUX2 ATXN2 TP63 MAST2 IL4R SOS2

1.71e-04361676EFO_0004568
DiseaseCoffin-Siris syndrome (implicated_via_orthology)

SMARCC1 ARID1A

1.81e-049672DOID:1925 (implicated_via_orthology)
Diseaseurate measurement

NCOA6 CUX2 ATXN2 PODXL FMN2 ARHGAP17 C11orf24 ARID1A SOS2

1.85e-04895679EFO_0004531
Diseasepulse pressure measurement

CUX2 TTBK1 WIPF1 RBM33 PODXL WASF2 POGZ MAST2 CPNE5 FAM186B SOS2

2.79e-0413926711EFO_0005763
DiseaseEndometrial Neoplasms

JAZF1 ARID1A EP300

3.16e-0458673C0014170
Diseasecancer (implicated_via_orthology)

PHC3 CUX2 TP63 SMARCC1 ARID1A

3.63e-04268675DOID:162 (implicated_via_orthology)
Diseasehair colour measurement

CUX2 PODXL TP63 JAZF1 FMN2 ZC3H18 ARID1A

4.87e-04615677EFO_0007822
Diseasebilirubin measurement

CUX2 ATXN2 JAZF1 ARID1A DNMBP SOS2

5.04e-04442676EFO_0004570
DiseaseIntellectual Disability

PRR12 CUX2 PCGF2 PTPN23 POGZ TAF6

5.35e-04447676C3714756
Diseasetestosterone measurement

IRF2BP2 NCOA6 CUX2 TTBK1 JAZF1 ARID1A DNMBP ZBTB42 SOS1 SOS2

5.77e-0412756710EFO_0004908
DiseaseEndometrial Carcinoma

JAZF1 ARID1A EP300

5.97e-0472673C0476089
DiseaseT-Cell Lymphoma

ARID1A EP300

5.97e-0416672C0079772
Diseaseserum alanine aminotransferase measurement

MMP25 CUX2 ATXN2 JAZF1 ARID1A DNMBP MPRIP SOS2

7.70e-04869678EFO_0004735
DiseaseHbA1c measurement

CUX2 AEBP1 ATXN2 JAZF1 MAST1 SOS1 SOS2

8.42e-04675677EFO_0004541
DiseaseNoonan-Like Syndrome With Loose Anagen Hair

SOS1 SOS2

8.47e-0419672C3501846
DiseaseCostello syndrome (disorder)

SOS1 SOS2

8.47e-0419672C0587248
DiseaseNoonan syndrome-like disorder with loose anagen hair

SOS1 SOS2

8.47e-0419672C1843181
DiseaseCardio-facio-cutaneous syndrome

SOS1 SOS2

8.47e-0419672C1275081
Diseasegout

CUX2 JAZF1 SMARCC1 SOS1

1.04e-03196674EFO_0004274
DiseaseLEOPARD Syndrome

SOS1 SOS2

1.14e-0322672C0175704
DiseaseNoonan Syndrome

SOS1 SOS2

1.36e-0324672C0028326
DiseaseCalcium channel blocker use measurement

TTBK1 ATXN2 WASF2 SOS2

1.42e-03213674EFO_0009930
DiseaseAdenoid Cystic Carcinoma

ARID1A CREBBP EP300

1.55e-03100673C0010606
DiseaseNephrotic Syndrome

CD2 PODXL

1.72e-0327672C0027726
DiseaseSezary Syndrome

ARID1A CREBBP

1.72e-0327672C0036920
Diseasediastolic blood pressure, unipolar depression

CUX2 ATXN2

2.12e-0330672EFO_0003761, EFO_0006336
Diseasecancer

PHC3 NCOA6 ATXN2 JAZF1 TRAK2

2.17e-03400675MONDO_0004992
DiseaseOvarian Mucinous Adenocarcinoma

MAST2 WNK4

2.26e-0331672C1335167

Protein segments in the cluster

PeptideGeneStartEntry
QALHPPPRQTPTPPT

EP300

876

Q09472
QPVPSPRPQSQPPHS

EP300

2311

Q09472
PRPQSQPPHSSPSPR

EP300

2316

Q09472
HPPVTSAPLSPPQPN

AMOT

191

Q4VCS5
PHTVPPTLPPAPATT

AEBP1

1046

Q8IUX7
STPQNPATSQHPPPP

CD2

271

P06729
SPRPQSQPPHSSPSP

CREBBP

2351

Q92793
PPPRPCTPVSTSPHL

DNMBP

611

Q6XZF7
RSPQTSPSHPQPLSP

FAM186B

181

Q8IYM0
ASPTEPRSSPSPPPS

CUX2

976

O14529
TPAPSPSPSPSPQAV

ANO8

1211

Q9HCE9
PPPPTLLNSSHPVPT

RBM33

486

Q96EV2
RPPVPLPAPSHPAST

MTA2

646

O94776
IPSHTAPRPNPTPAP

PTPN23

891

Q9H3S7
PPLSPPPTTSPHKQT

GPHN

191

Q9NQX3
KPPTPASTPHSQIPP

ARID1A

1161

O14497
APPPQPPASPTHSPS

MMP25

296

Q9NPA2
SSRPPPPFTTHSPPT

MUC6

1566

Q6W4X9
PHPTSPLSPRQPTST

PODXL

181

O00592
PPPTLSSGSPPQPRH

MBD6

441

Q96DN6
PPLSPPSPSTPNHRR

MPRIP

286

Q6WCQ1
SRPPSRPSRPPSHPS

ATXN2

586

Q99700
PRHSSGSLTPPVTPP

JAZF1

101

Q86VZ6
PPTPASHSPSPSLPA

PER1

946

O15534
PSVPPIPSVHPVPSQ

CSPP1

496

Q1MSJ5
ASTPIPPTPQAPSPA

NES

386

P48681
KPHPPPPPATRGTST

KIF26A

321

Q9ULI4
VVVSPPPPHSPSQSP

PHC3

396

Q8NDX5
PLAHTPSPTQASPPP

MAST1

1206

Q9Y2H9
GPPATHPTSPTPPST

PCGF2

291

P35227
PSLATVQTPSHPPPP

NCOA6

361

Q14686
PPPLSMPSTSHCTPP

TP63

526

Q9H3D4
PPRSPQSSHLPSSSP

IL4R

661

P24394
LAHTPSPPPPTASPQ

MAST2

1346

Q6P0Q8
HQPTQSISQPPPPPS

FMN2

801

Q9NZ56
PPPTASPHSNRTTPP

IRF2BP2

401

Q7Z5L9
RPPPAAPTHSPSQSP

CPNE5

566

Q9HCH3
HTHPPSPPSRLPSPD

MICAL2

896

O94851
TIPPTFPPAHSSTPP

MUC17

4061

Q685J3
SPRPGPPPSTSSPHL

MAP4K1

436

Q92918
PTSHPSPVPPPASSP

TAF6

621

P49848
PNSPSTPPSTPSPRV

SOS2

1256

Q07890
AAPAPTHVRSPQPPP

VGF

496

O15240
ETPPQPPPRSRSSHS

SYNJ1

1281

O43426
PAPPPSRPSSPVHVA

MAP3K21

106

Q5TCX8
QHPPSLSPKPPTRSP

ARHGAP17

661

Q68EM7
PTRSPSPPTQHTGQP

ARHGAP17

671

Q68EM7
SHTPPQTPTPPSTPP

ARHGAP17

751

Q68EM7
PASTATPPPTPTHPQ

POGZ

911

Q7Z3K3
ALTTPPPQASPSPSP

PRR36

491

Q9H6K5
PVSPSATPPSQAPPS

PRR36

906

Q9H6K5
PSQPSSSTVPPPPHR

PRRC2C

701

Q9Y520
PPPPTAQSTQPTPHG

PRR12

766

Q9ULL5
RSPDPSPSPHPTTTP

SSC5D

1141

A1L4H1
FTPPPPQTPSPHGTR

SOS1

1256

Q07889
KHSPSPPPPTPTESR

SMARCC1

326

Q92922
SASAPRLPVPHPPSP

LINC00477

121

Q96M19
PTSAPAPTQPAPTPT

C15orf39

671

Q6ZRI6
PTASPVPVPHTSPIP

C11orf24

301

Q96F05
PDSTHPSPPSTPPSL

SLC35G4

11

P0C7Q5
TPSSHPTSPPPASPP

TNRC18

1026

O15417
TPPNSPSHSPCPSPL

TRAK2

776

O60296
PSSPVRAPPDSPTTP

TTBK1

431

Q5TCY1
TPPPKTRHSPTPQQS

SRRM1

406

Q8IYB3
SPSPPPKRRVSHSPP

SRRM1

626

Q8IYB3
PVPSTPRPIQSSPHN

WIPF1

186

O43516
STPRPSASSQAPPPP

WIPF1

296

O43516
SQRGLTSPHPPTPPP

SOCS7

296

O14512
RSSVVSPSHPPPAPP

WASF2

291

Q9Y6W5
SSSSRSPHSPPKPPP

ZBTB42

236

B2RXF5
LSPTPSPPTPAPQHS

RIPOR1

756

Q6ZS17
ITSPPCHPSPSPFSP

WNK4

831

Q96J92
PSPSPTPSPHRPSIR

ZC3H18

606

Q86VM9
PPPPETTMHPTTASP

WFIKKN2

186

Q8TEU8